JA Nettleton, R Katz - Journal of the American Dietetic Association, 2005 - Elsevier Historically, epidemiologic studies have reported a lower prevalence of impaired
glucose tolerance and type 2 diabetes in populations consuming large amounts of
the n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs) found mainly ... Cited by 123 - Related articles - All 13 versions
RM Crooke, MJ Graham, KM Lemonidis, CP … - The Journal of Lipid Research, 2005 - ASBMB High levels of plasma apolipoprotein B-100 (apoB-100), the principal
apolipoprotein of LDL, are associated with cardiovascular disease. We
hypothesized that suppression of apoB-100 mRNA by an antisense ... Cited by 72 - Related articles - All 4 versions
- ►cnfindpark.cn YA Carpentier, L Portois, WJ Malaisse - American Journal of Clinical Nutrition, 2006 - ajcn.cnfindpark.cn The metabolic syndrome is defined as the coexistence of 3 or more components,
some of which indicate alterations in glucose and lipid metabolism. The
prevalence of the metabolic syndrome is rapidly increasing in relation to ... Cited by 69 - Related articles - BL Direct - All 8 versions
J Araya, R Rodrigo, LA Videla, L Thielemann, M … - Clinical Science, 2004 - cs.portlandpress.com Hepatic steatosis is a major feature associated with NAFLD (non-alcoholic fatty
liver disease). The aims of the present study were to assess the levels of PUFA
(polyunsaturated fatty acids) in liver total lipids, triacylglycerols ( ... Cited by 73 - Related articles - View as HTML - BL Direct - All 12 versions
- ►darkmay.cz [PDF] WS Harris, M Miller, AP Tighe, MH Davidson, … - Atherosclerosis, 2007 - Elsevier The most common omega-3 fatty acids contain 18–22 carbons and a signature
double bond at the third position from the methyl (or n, or omega) end of the
molecule. These fatty acids must be obtained in the diet as they cannot be ... Cited by 52 - Related articles - All 19 versions
MH Davidson, EA Stein, HE Bays, KC Maki, … - Clinical Therapeutics, 2007 - Elsevier Methods: This was a multicenter, randomized, double-blind, placebo-controlled,
parallel-group study in adults who had received ≥8 weeks of stable statin
therapy and had mean fasting TG levels ≥200 and <500 mg/dL and mean low- ... Cited by 52 - Related articles - All 2 versions
- ►jlr.org S Bilz, S Wagner, M Schmitz, A Bedynek, U … - The Journal of Lipid Research, 2004 - ASBMB Kinetics of apo B and apo AI were assessed in 8 patients with mixed
hyperlipidemia at baseline and after 8 weeks of atorvastatin 80 mg qd and
micronised fenofibrate 200 mg qd in a cross-over study. Both increased ... Cited by 47 - Related articles - BL Direct - All 5 versions
- ►endojournals.org HN Ginsberg - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Context: The Adult Treatment Panel III recommends 3-hydroxy-3-methylglutaryl
coenzyme A reductase inhibitors, or statins, as first-line lipid-altering
therapy for all adult patients with diabetes mellitus. This is based on the ... Cited by 44 - Related articles - BL Direct - All 4 versions
JG Robinson, NJ Stone - The American journal of cardiology, 2006 - Elsevier Omega-3 fatty acids from both marine and plant sources have been shown to reduce
the risk of coronary artery disease death. Although their beneficial
cardiovascular effects are thought to be due to their antiarrhythmic ... Cited by 43 - Related articles - All 15 versions
